Drug therapy for portal hypertension.
作者信息
Lebrec D
机构信息
Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481 and Service d'Hépatologie, Hôpital Beaujon, Clichy, France.
出版信息
Gut. 2001 Sep;49(3):441-2. doi: 10.1136/gut.49.3.441.
Abstract
摘要
相似文献
1
Drug therapy for portal hypertension.门静脉高压的药物治疗
Gut. 2001 Sep;49(3):441-2. doi: 10.1136/gut.49.3.441.
2
Pharmacological treatment of portal hypertension.
Prog Liver Dis. 1995;13:269-92.
3
[Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
Klin Med (Mosk). 1995;73(2):12-6.
4
[Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
Dtsch Med Wochenschr. 1986 Feb 21;111(8):306-13. doi: 10.1055/s-2008-1068447.
5
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.门静脉高压和食管静脉曲张所致胃肠道出血的药物治疗
Curr Gastroenterol Rep. 2006 Feb;8(1):7-13. doi: 10.1007/s11894-006-0058-9.
6
[Chemotherapy of portal hypertension].[门静脉高压症的化疗]
Klin Med (Mosk). 1991 Apr;69(4):28-32.
7
Pharmacologic Management of Portal Hypertension.门静脉高压症的药物治疗。
Clin Liver Dis. 2019 Nov;23(4):713-736. doi: 10.1016/j.cld.2019.06.004. Epub 2019 Aug 7.
8
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].[药物治疗在静脉曲张出血治疗中降低门静脉压力的重要性]
Dtsch Med Wochenschr. 2009 Sep;134(37):1823-7. doi: 10.1055/s-0029-1237518. Epub 2009 Sep 2.
9
[Drug therapy of acute esophageal varices bleeding (vasopressin, terlipressin, somatostatin)].急性食管静脉曲张出血的药物治疗（血管加压素、特利加压素、生长抑素）
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1538-9.
10
Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis.急性静脉曲张出血：药物治疗及一级/二级预防
Best Pract Res Clin Gastroenterol. 2008;22(2):279-94. doi: 10.1016/j.bpg.2007.11.001.
引用本文的文献
1
β-blockers in advanced cirrhosis: More friend than enemy.β受体阻滞剂在晚期肝硬化中的应用：利大于弊。
Clin Mol Hepatol. 2021 Jul;27(3):425-436. doi: 10.3350/cmh.2020.0234. Epub 2020 Dec 3.
本文引用的文献
1
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension.普萘洛尔预防肝硬化患者大食管静脉曲张无效：一项随机试验。法语门静脉高压研究俱乐部。
Eur J Gastroenterol Hepatol. 1999 Jul;11(7):741-5. doi: 10.1097/00042737-199907000-00011.
2
Pharmacological treatment of portal hypertension: present and future.门静脉高压症的药物治疗：现状与未来
J Hepatol. 1998 May;28(5):896-907. doi: 10.1016/s0168-8278(98)80241-9.
3
Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.β-肾上腺素能拮抗剂预防肝硬化患者胃肠道再出血的荟萃分析
Hepatology. 1997 Jan;25(1):63-70. doi: 10.1053/jhep.1997.v25.pm0008985266.
4
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.酒精性肝硬化患者的门静脉高压、食管静脉曲张大小与胃肠道出血风险
Gastroenterology. 1980 Dec;79(6):1139-44.
5
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.β-肾上腺素能拮抗剂药物预防肝硬化和食管静脉曲张患者胃肠道出血。来自四项随机临床试验的589例患者的数据及预后因素分析。法意多中心研究组
N Engl J Med. 1991 May 30;324(22):1532-8. doi: 10.1056/NEJM199105303242202.
Zotero 插件